RV

Reshma Vijay Lokhande

Active Director Director DIN 09461747
DIN 09461747 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Reshma Vijay Lokhande

Data last updated:

Reshma Vijay Lokhande is a Director at Trams Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Trams Pharmaceuticals Private Limited reported revenue of ₹6.5 Lakh (FY 2024).

DIN 09461747
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2022
Oldest Company Age 4 yrs
Largest company Trams Pharmaceuticals Private Limited · ₹6.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20222022₹6.5 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Trams Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reshma Vijay Lokhande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reshma Vijay Lokhande

Reshma Vijay Lokhande currently holds 1 directorship: Trams Pharmaceuticals Private Limited (Director, since 10 Feb 2022, revenue ₹6.5 Lakh (FY 2024)).

Reshma Vijay Lokhande was first appointed on 10 Feb 2022 as Director at Trams Pharmaceuticals Private Limited.

The current boards of Reshma Vijay Lokhande's companies include Ashwini Balu Nakade (Trams Pharmaceuticals Private Limited), Manisha Mahesh Marne (Trams Pharmaceuticals Private Limited), Sangeeta Deepak Lokhande (Trams Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available